Follicle-stimulating hormone induced Epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway

International Journal of Gynecological Cancer

Volumn 24, Issue 9, 2014, Pages 1564-1574

  Yang, Yongbin ^a,b   Zhang, Jiawen ^b,c   Zhu, Yaping ^b   Zhang, Zhenbo ^b   Sun, Hong ^a   Feng, Youji ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

Epithelial ovarian cancer; Epithelial mesenchymal transition; Follicle stimulating hormone; FSH receptor; Phosphatidylinositol 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COMPLEMENTARY DNA; FOLLITROPIN; FOLLITROPIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; HORMONE; MESSENGER RNA; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CELL INVASION ASSAY; CELL MIGRATION; DNA TRANSFECTION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; HORMONE ACTION; OVARIAN CANCER CELL LINE; OVARY CARCINOMA; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DRUG EFFECTS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, FSH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84925945994     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000279     Document Type: Article

References (27)

1. Ozols RF, Bookman MA, Connolly DC, et al. Focus on epithelial ovarian cancer. Cancer Cell. 2004;5:19-24. doi:10.1016/S1535-6108 (04) 00002-9.
2. Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer. 2005;5:355-366. doi: 10.1038/nrc1611.
3. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679-695. doi: 10.1016/j.cell.2006.11.001.
4. Islam S, Carey TE, Wolf GT, et al. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol. 1996;135(6 Pt 1):1643-1654. doi: 10.1083/jcb.135.6.1643.
5. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871-890. doi: 10.1016/j.cell.2009.11.007.
6. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14:818-829. doi: 10.1016/j.devcel.2008.05.009.
7. Stadel BV. Letter: the etiology and prevention of ovarian cancer. Am J Obstet Gynecol. 1975;123:772-774.
8. Mertens-Walker I, Baxter RC, Marsh DJ. Gonadotropin signalling in epithelial ovarian cancer. Cancer Lett. 2012;324:152-159. doi: 10.1016/j.canlet.2012.05.017.
9. Gnagy S, Ming EE, Devesa SS, et al. Declining ovarian cancer rates in U. S. women in relation to parity and oral contraceptive use. Epidemiology. 2000;11:102-105.
10. Sanner K, Conner P, Bergfeldt K, et al. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril. 2009;91:1152-1158. doi: 10.1016/j.fertnstert.2008.01.073.
11. Halperin R, Hadas E, Langer R, et al. Peritoneal fluid gonadotropins and ovarian hormones in patients with ovarian cancer. Int J Gynecol Cancer. 1999;9:502-507. doi: 10.1046/j.1525-1438.1999.99075.x.
12. Thomas CM, Boss EA, Boonstra H, et al. Gonadotropins and female sex steroid hormones in cyst fluid and serum from patients with ovarian tumors. Eur J Gynaecol Oncol. 2008;29:468-472.
13. Huang Y, Jin H, Liu Y, et al. FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5. Endocr Relat Cancer. 2011;18:13-26. doi: 10.1677/ERC-09-0308.
14. Zhang Z, Jia L, Feng Y, et al. Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer. Cancer Lett. 2009;278:56-64. doi: 10.1016/j.canlet.2008.12.024.
15. Choi JH, Choi KC, Auersperg N, et al. Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells. Cancer Res. 2006;66:3912-3920. doi: 10.1158/0008-5472. CAN-05-1785.
16. Cao L, Shao M, Schilder J, et al. Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene. 2012;31:2521-2534. doi: 10.1038/onc.2011.429onc2011429.
17. Cheng JC, Auersperg N, Leung PC. EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells? PLoS One. 2012;7:e34071. doi: 10.1371/journal.pone.0034071.
18. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90:1774-1786. doi: 10.1093/jnci/90.23.1774.
19. Chen FC, Oskay-Ozcelik G, Buhling KJ, et al. Prognostic value of serum and ascites levels of estradiol, FSH, LH and prolactin in ovarian cancer. Anticancer Res. 2009;29:1575-1578.
20. Ohtani K, Sakamoto H, Kikuchi A, et al. Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system. Cancer Lett. 2001;166:207-213. doi: 10.1016/S0304-3835 (00) 00713-8.
21. La Vecchia C. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev. 2001;10:125-129. doi: 10.1097/00008469-200104000-00002.
22. Radu A, Pichon C, Camparo P, et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med. 2010;363:1621-1630. doi: 10.1056/NEJMoa1001283.
23. Cheng JC, Auersperg N, Leung PC. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin. Oncogene. 2011;30:1020-1031. doi: 10.1038/onc.2010.486.
24. Cheng JC, Chang HM, Leung PC. Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression. J Clin Endocrinol Metab. 2012;97:E1380-E1389. doi: 10.1210/jc.2011-2751.
25. Grotegut S, von Schweinitz D, Christofori G, et al. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 2006;25:3534-3545. doi: 10.1038/sj.emboj.7601213.
26. Cheng JC, Auersperg N, Leung PC. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. PLoS One. 2012;7:e42436. doi: 10.1371/journal.pone.0042436.
27. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442-454. doi: 10.1038/nrc822.